孕前eGFR与不良母胎结局风险:一项基于人群的研究
加拿大安大略省基于人群的回顾性队列研究纳入565,907次妊娠,分析孕前2年内至受孕后30天内的血清肌酐。结果显示,随着eGFR下降,主要母体疾病、早产和低出生体重风险单调增加,eGFR低于60 ml/min per 1.73 m²时风险增加最明显;各eGFR分层中蛋白尿均进一步增加风险。
要点
- eGFR<45 ml/min per 1.73 m²的133次妊娠中56次(40%)在37周前分娩,eGFR>90时为10%。
- 主要母体疾病、早产和低出生体重风险随eGFR下降单调增加。
- 各eGFR分层中,蛋白尿水平更高均显著增加不良结局风险。
核心结论
- 低eGFR且合并蛋白尿的女性不良妊娠结局发生率更高,结果可用于卫生政策、孕前咨询和妊娠随访。
研究设计与样本
- 加拿大安大略省回顾性、基于人群的队列研究,纳入2007年至2019年分娩、未透析且未接受肾移植的女性。
- 共纳入462,053名女性的565,907次妊娠,分析受孕前2年内至受孕后30天内测定的血清肌酐,并评估有尿蛋白数据者的影响。
主要发现
- 主要母体疾病、早产和低出生体重的风险随eGFR类别下降单调增加,eGFR降至60 ml/min per 1.73 m²以下时风险增加最明显。
- eGFR<45 ml/min per 1.73 m²的133次妊娠中56次(40%)在37周前分娩,eGFR>90 ml/min per 1.73 m²的妊娠中为10%。
- 各eGFR类别内,蛋白尿程度更高均显著增加风险。
- 无论基线eGFR如何,母体和新生儿死亡均罕见(所有妊娠<0.3%)。
- eGFR<45 ml/min per 1.73 m²的女性中,仅7%在妊娠期间或之后立即接受透析。
关键数值与推荐
- eGFR<45 ml/min per 1.73 m²的133次妊娠中56次(40%)在37周前分娩,eGFR>90 ml/min per 1.73 m²的妊娠中为10%。
- 所有妊娠中母体和新生儿死亡<0.3%。
- eGFR<45 ml/min per 1.73 m²的女性中7%在妊娠期间或之后立即接受透析。
临床怎么用
- 作者认为,这些结果有助于卫生政策制定、孕前咨询和慢性肾脏病女性的妊娠随访。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SIGNIFICANCE STATEMENT: Pregnancies in women with CKD carry greater risk than pregnancies in the general population. The small number of women in prior studies has limited estimates of this risk, especially among those with advanced CKD. We report the results of a population-based cohort study in Ontario, Canada, that assessed more than 500,000 pregnancies, including 600 with a baseline eGFR < 60 ml/min per 1.73 m 2 . The investigation demonstrates increases in risk of different adverse maternal and fetal outcomes with lower eGFR and further risk elevation with baseline proteinuria. BACKGROUND: CKD is a risk factor for pregnancy complications, but estimates for adverse outcomes come largely from single-center studies with few women with moderate or advanced stage CKD. METHODS: To investigate the association between maternal baseline eGFR and risk of adverse pregnancy outcomes, we conducted a retrospective, population-based cohort study of women (not on dialysis or having had a kidney transplant) in Ontario, Canada, who delivered between 2007 and 2019. The study included 565,907 pregnancies among 462,053 women. Administrative health databases captured hospital births, outpatient laboratory testing, and pregnancy complications. We analyzed pregnancies with serum creatinine measured within 2 years of conception up to 30 days after conception and assessed the impact of urine protein where available. RESULTS: The risk of major maternal morbidity, preterm delivery, and low birthweight increased monotonically across declining eGFR categories, with risk increase most notable as eGFR dropped below 60 ml/min per 1.73 m 2 . A total of 56 (40%) of the 133 pregnancies with an eGFR <45 ml/min per 1.73 m 2 resulted in delivery under 37 weeks, compared with 10% of pregnancies when eGFR exceeded 90 ml/min per 1.73 m 2 . Greater proteinuria significantly increased risk within each eGFR category. Maternal and neonatal deaths were rare regardless of baseline eGFR (<0.3% of all pregnancies). Only 7% of women with an eGFR <45 ml/min per 1.73 m 2 received dialysis during or immediately after pregnancy. CONCLUSIONS: We observed higher rates of adverse pregnancy outcomes in women with low eGFR with concurrent proteinuria. These results can help inform health care policy, preconception counseling, and pregnancy follow-up in women with CKD.
引用
- Tangren J, Bathini L, Jeyakumar N, et al. Pre-Pregnancy eGFR and the Risk of Adverse Maternal and Fetal Outcomes: A Population-Based Study. J Am Soc Nephrol. 2023. PMID: 36735377. doi:10.1681/ASN.0000000000000053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。